TransAct Technologies Incorporated TACT
4.87
(0.04)
(0.81%)
as of 25 Sep
- Market cap
- $50.7M
- P/E
- 0.0×
Follow TACT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(23.00%) | (4.02%) | (1.56%) | (1.25%) | |
| (16.89%) | (2.79%) | (1.07%) | (0.84%) | ||
ROIC |
(6.97%) | (8.28%) | (2.92%) | (2.00%) | |
Return on Tangible Assets |
(29.10%) | (4.59%) | (1.79%) | (1.52%) | |
Average Days of Receivables |
42.41 | 45.12 | 62.33 | 71.35 | |
Free Cash Flow per Share |
0.79 | 0.60 | 0.46 | 0.17 | |
Free Cash Flow |
8.00 | 6.06 | 4.73 | 1.76 | |
Capital Expenditures |
(1.45) | (1.61) | (2.16) | (3.69) | |
Piotroski F-Score |
3.00 | 4.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
18.24% | 14.88% | 13.47% | 10.46% | |
Accounts Receivable Turnover |
7.58 | 8.00 | 5.84 | 5.83 | |
Accounts Payable Turnover |
7.57 | 6.53 | 5.93 | 5.97 | |
Inventory Turnover |
1.83 | 1.96 | 2.25 | 2.42 | |
Average Days of Payables |
51.65 | 48.81 | 59.82 | 68.73 | |
Days of Inventory on Hand |
163.67 | 149.75 | 129.75 | 124.17 | |
Tax Rate |
6.05 | 0.14 | 0.35 | 0.42 | |
Research and Development Expense of Revenue |
13.11% | 13.02% | 12.20% | 11.22% | |
Selling, General and Administrative Expense of Revenue |
37.42% | 38.32% | 38.02% | 39.13% | |
Share Based Compensation of Revenue |
3.15% | 3.50% | 3.77% | 3.76% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.17) | (6.19) | (13.97) | (13.62) | |
Depreciation/Fixed assets |
0.50 | 0.54 | 0.56 | 0.57 | |
Capex/Depreciation |
(2.07) | (2.40) | (3.29) | (5.92) | |
Revenue per Share |
4.97 | 5.10 | 5.19 | 5.15 | |
Operating CF per Share |
0.94 | 0.76 | 0.68 | 0.53 | |
Capex per Share |
(0.14) | (0.16) | (0.21) | (0.36) | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.07 | |
Net Profit Margin |
(16.05%) | (2.41%) | (0.93%) | (0.75%) |
Columns are period end dates